Rojas E.R.
291
Coauthors
24
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 4 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 5 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Genética | 9 |
| Enfermedad cardiovascular | 8 |
| Medicina interna | 7 |
| Fisiología | 5 |
| Bioquímica | 4 |
| Medicamento | 4 |
| Nutrición | 3 |
| Obesidad | 3 |
| Farmacología | 2 |
| Migración humana | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 19 |
| Fisiología humana | 11 |
| Farmacología y terapéutica | 8 |
| Salud y seguridad personal | 6 |
| Medicina y salud | 3 |
| Bioquímica | 3 |
| Problemas sociales y servicios a grupos | 2 |
| Tecnología alimentaria | 1 |
| Alimentación y bebidas | 1 |
| Microorganismos, hongos y algas | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 24 |
| Google Scholar | 1 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 24 |
| Velasco M. | 12 |
| Rojas-Quintero J. | 9 |
| Faria J. | 8 |
| Aparicio D. | 8 |
| Arráiz N. | 7 |
| Cano-Ponce C. | 7 |
| Salazar-Vílchez J. | 6 |
| Reyna-Villasmil N. | 5 |
| Martínez M.S. | 5 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Approach to a successful selection of antihypertensive drugs for the patient with atherosclerosis
ArticleAbstract: Coronary heart disease has become a medical and public health issue associated with multiple risk faPalabras claves:ACE inhibitors, atherosclerosis, Coronary heart disease, Hypertension, myocardial infarctionAutores:Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusTargeting hypertension in patients with cardiorenal metabolic syndrome
ReviewAbstract: Diabetes mellitus coexisting with hypertension is greater than chance alone would pbkp_redict. HyperPalabras claves:Antihypertensive therapy, Blood pressure, Cardiorenal metabolic syndrome, DIABÉTES, Hypertension, Kidney disease, Pharmacologic therapy, RAAS, Reninangiotensin- aldosterone systemAutores:Bolli P., Israili Z.H., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusDiagnostic criteria and management of metabolic syndrome: Evolution overtime
ReviewAbstract: The beginnings of the Metabolic Syndrome (MetS) as a suspected, not yet recognized entity can be traPalabras claves:Cardiovascular disease, Diagnostic criteria, management, Metabolic syndrome, MetS updates, Type 2 DiabetesAutores:Carrasquero R., Castro A., Lameda V., Manzano A., Nava M., Rojas E.R., Suarez M.K., Valmore BermúdezFuentes:scopusInfection, inflammation and atherosclerotic vascular disease
ReviewAbstract: Cardiovascular disease (CVD) is the leading cause of death in developed countries. The causes of thiPalabras claves:atherosclerosis, Cardiovascular disease, Chlamydia, infection, inflammation, risk factorAutores:Aparicio D., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Martínez Y., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusThe role of adiponectin in endothelial dysfunction and hypertension
ArticleAbstract: It has been two decades since the discovery of adiponectin, and today its role in insulin resistancePalabras claves:adiponectin, Endothelial dysfuction, Hypertension, Nitric oxide, obesity, renin-angiotensin-aldosterone systemAutores:Bolli P., Faria J., Fidilio E., Israili Z.H., Rodríguez-Molina D., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopus